Eclampsia in the United Kingdom (original) (raw)

Abstract

OBJECTIVES--To measure the incidence of eclampsia, establish how often it is preceded by signs of pre-eclampsia, document the morbidity associated with eclampsia, and determine the maternal case fatality rates. DESIGN--A prospective, descriptive study of every case of eclampsia in the United Kingdom in 1992. Information was collected from reviews of hospital case notes and questionnaires to general practitioners. SETTING--All 279 hospitals in the United Kingdom with a consultant obstetric unit. RESULTS--Obstetricians and midwives notified 582 possible cases, and 383 were confirmed as eclampsia. The national incidence of eclampsia was 4.9/10,000 maternities (95% confidence interval 4.5 to 5.4). Most convulsions occurred despite antenatal care (70%) and within one week of the woman's last visit to a doctor or midwife (85%). Three quarters of first seizures occurred in hospital, of which 38% developed before both proteinuria and hypertension had been documented. Forty four per cent of cases occurred postpartum, more than a third (38%) antepartum, and the remainder (18%) intrapartum. Nearly one in 50 women (1.8%) died, and 35% of all women had at least one major complication. The rate of stillbirths and neonatal deaths was 22.2/1000 and 34.1/1000, respectively. Preterm eclampsia occurred more commonly antepartum and was associated with more maternal complications and fetuses that were small for gestational age, as well as with higher rates of stillbirth and neonatal mortality. Antepartum eclampsia, which was more likely to occur preterm, was associated with a higher rate of maternal complications and a higher neonatal mortality. Both factors (gestational prematurity and antepartum occurrence) contributed independently to the severity of the outcome. CONCLUSION--Eclampsia occurs in nearly one in 2000 maternities in the United Kingdom and is associated with high maternal morbidity and fatality in cases. It may present unheralded by warning signs. Preterm and antenatal eclampsia seem to be particularly severe.

1395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CORKILL T. F. Experience of toxaemia control in Australia and New Zealand. Pathol Microbiol (Basel) 1961;24:428–434. doi: 10.1159/000161149. [DOI] [PubMed] [Google Scholar]
  2. Douglas K. A., Redman C. W. Eclampsia in the United Kingdom. The 'BEST' way forward. Br J Obstet Gynaecol. 1992 May;99(5):355–356. doi: 10.1111/j.1471-0528.1992.tb13745.x. [DOI] [PubMed] [Google Scholar]
  3. Hall M., Campbell D. Cost-effectiveness of present programs for detection of asymptomatic hypertension in relation to the severity of hypertension and proteinuric hypertension. Int J Technol Assess Health Care. 1992;8 (Suppl 1):75–81. doi: 10.1017/s0266462300012940. [DOI] [PubMed] [Google Scholar]
  4. López-Llera M. Main clinical types and subtypes of eclampsia. Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):4–9. doi: 10.1016/0002-9378(92)91816-s. [DOI] [PubMed] [Google Scholar]
  5. Moodley J., Naicker R. S., Mankowitz E. Eclampsia--a method of management. A preliminary report. S Afr Med J. 1983 Apr 2;63(14):530–535. [PubMed] [Google Scholar]
  6. Möller B., Lindmark G. Eclampsia in Sweden, 1976-1980. Acta Obstet Gynecol Scand. 1986;65(4):307–314. doi: 10.3109/00016348609157350. [DOI] [PubMed] [Google Scholar]
  7. Redman C. W., Jefferies M. Revised definition of pre-eclampsia. Lancet. 1988 Apr 9;1(8589):809–812. doi: 10.1016/s0140-6736(88)91667-4. [DOI] [PubMed] [Google Scholar]
  8. Roberts J. M., Redman C. W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993 Jun 5;341(8858):1447–1451. doi: 10.1016/0140-6736(93)90889-o. [DOI] [PubMed] [Google Scholar]
  9. Roberts J. M., Redman C. W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993 Jun 5;341(8858):1447–1451. doi: 10.1016/0140-6736(93)90889-o. [DOI] [PubMed] [Google Scholar]
  10. Saftlas A. F., Olson D. R., Franks A. L., Atrash H. K., Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 1990 Aug;163(2):460–465. doi: 10.1016/0002-9378(90)91176-d. [DOI] [PubMed] [Google Scholar]
  11. Sibai B. M., Abdella T. N., Spinnato J. A., Anderson G. D. Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol. 1986 Mar;154(3):581–586. doi: 10.1016/0002-9378(86)90605-8. [DOI] [PubMed] [Google Scholar]
  12. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982 Jan 15;142(2):159–167. doi: 10.1016/s0002-9378(16)32330-4. [DOI] [PubMed] [Google Scholar]
  13. Wightman H., Hibbard B. M., Rosen M. Perinatal mortality and morbidity associated with eclampsia. Br Med J. 1978 Jul 22;2(6132):235–237. doi: 10.1136/bmj.2.6132.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yudkin P. L., Aboualfa M., Eyre J. A., Redman C. W., Wilkinson A. R. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev. 1987 Jan;15(1):45–52. doi: 10.1016/0378-3782(87)90099-5. [DOI] [PubMed] [Google Scholar]